Physician profile
Bryan James Levay
NPI 1427457290
$1,472.45
in general payments reported to CMS, 2019-2025
22 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $29.94 · 2021: $257 · 2022: $157 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $253 · Food and Beverage: $46.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $252.79 |
| Food and Beverage | $46.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $410.39 | 2021-2025 | |
| Depuy Synthes Sales INC. | $100.78 | 2019 | |
| Integra Lifesciences Corporation | $100.73 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $98.41 | 2019 | |
| Stryker Corporation | $98.20 | 2019-2020 | |
| Smith+Nephew, INC. | $97.39 | 2019-2021 | |
| Sebela Pharmaceuticals INC. | $73.69 | 2019 | |
| Paratek Pharmaceuticals, INC. | $68.65 | 2022 | |
| Merck Sharp & Dohme LLC | $58.23 | 2019 | |
| Misonix INC | $44.23 | 2019 | |
| Arthrosurface Incorporated | $43.78 | 2019 | |
| Wright Medical Technology, INC. | $40.57 | 2019 | |
| Nabriva Therapeutics, Plc | $33.77 | 2021-2022 | |
| Horizon Therapeutics Plc | $33.25 | 2019-2021 | |
| Averitas Pharma INC. | $31.29 | 2025 | Qutenza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $28.82 | 2019-2025 | |
| Melinta Therapeutics, LLC | $26.16 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.36 | 2019 | |
| Kerecis Limited | $20.93 | 2019 | |
| Organogenesis INC. | $19.09 | 2021 | |
| Glenmark Therapeutics INC. | $19.00 | 2019 | |
| Orthofix Medical, INC. | $1.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Levay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.